Adverum Biotechnologies (ADVM) Competitors $6.17 -0.08 (-1.28%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends ADVM vs. BDTX, CHRS, CRTX, CCCC, SGMO, PRTC, TERN, MREO, ARCT, and YMABShould you be buying Adverum Biotechnologies stock or one of its competitors? The main competitors of Adverum Biotechnologies include Black Diamond Therapeutics (BDTX), Coherus BioSciences (CHRS), Cortexyme (CRTX), C4 Therapeutics (CCCC), Sangamo Therapeutics (SGMO), PureTech Health (PRTC), Terns Pharmaceuticals (TERN), Mereo BioPharma Group (MREO), Arcturus Therapeutics (ARCT), and Y-mAbs Therapeutics (YMAB). These companies are all part of the "medical" sector. Adverum Biotechnologies vs. Black Diamond Therapeutics Coherus BioSciences Cortexyme C4 Therapeutics Sangamo Therapeutics PureTech Health Terns Pharmaceuticals Mereo BioPharma Group Arcturus Therapeutics Y-mAbs Therapeutics Adverum Biotechnologies (NASDAQ:ADVM) and Black Diamond Therapeutics (NASDAQ:BDTX) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, analyst recommendations, media sentiment, profitability and earnings. Which has stronger earnings & valuation, ADVM or BDTX? Black Diamond Therapeutics has lower revenue, but higher earnings than Adverum Biotechnologies. Black Diamond Therapeutics is trading at a lower price-to-earnings ratio than Adverum Biotechnologies, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAdverum Biotechnologies$3.60M35.65-$117.17M-$5.99-1.03Black Diamond TherapeuticsN/AN/A-$82.44M-$1.33-1.83 Do analysts rate ADVM or BDTX? Adverum Biotechnologies presently has a consensus price target of $27.83, indicating a potential upside of 351.11%. Black Diamond Therapeutics has a consensus price target of $15.50, indicating a potential upside of 537.86%. Given Black Diamond Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Black Diamond Therapeutics is more favorable than Adverum Biotechnologies.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Adverum Biotechnologies 0 Sell rating(s) 1 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.83Black Diamond Therapeutics 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is ADVM or BDTX more profitable? Adverum Biotechnologies' return on equity of -65.14% beat Black Diamond Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Adverum BiotechnologiesN/A -65.14% -40.52% Black Diamond Therapeutics N/A -68.08%-49.65% Does the media refer more to ADVM or BDTX? In the previous week, Adverum Biotechnologies had 10 more articles in the media than Black Diamond Therapeutics. MarketBeat recorded 11 mentions for Adverum Biotechnologies and 1 mentions for Black Diamond Therapeutics. Black Diamond Therapeutics' average media sentiment score of 1.92 beat Adverum Biotechnologies' score of 0.64 indicating that Black Diamond Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Adverum Biotechnologies 3 Very Positive mention(s) 3 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Black Diamond Therapeutics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Does the MarketBeat Community believe in ADVM or BDTX? Adverum Biotechnologies received 318 more outperform votes than Black Diamond Therapeutics when rated by MarketBeat users. However, 69.86% of users gave Black Diamond Therapeutics an outperform vote while only 60.39% of users gave Adverum Biotechnologies an outperform vote. CompanyUnderperformOutperformAdverum BiotechnologiesOutperform Votes36960.39% Underperform Votes24239.61% Black Diamond TherapeuticsOutperform Votes5169.86% Underperform Votes2230.14% Do institutionals and insiders believe in ADVM or BDTX? 48.2% of Adverum Biotechnologies shares are held by institutional investors. Comparatively, 95.5% of Black Diamond Therapeutics shares are held by institutional investors. 4.2% of Adverum Biotechnologies shares are held by insiders. Comparatively, 8.9% of Black Diamond Therapeutics shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Which has more risk & volatility, ADVM or BDTX? Adverum Biotechnologies has a beta of 1.02, meaning that its stock price is 2% more volatile than the S&P 500. Comparatively, Black Diamond Therapeutics has a beta of 2.51, meaning that its stock price is 151% more volatile than the S&P 500. SummaryBlack Diamond Therapeutics beats Adverum Biotechnologies on 9 of the 16 factors compared between the two stocks. Ad Porter & CompanyElection warning coming true… If you missed it, my emergency election broadcast is now available - watch it before it's too late.Click here to watch it now. Get Adverum Biotechnologies News Delivered to You Automatically Sign up to receive the latest news and ratings for ADVM and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ADVM vs. The Competition Export to ExcelMetricAdverum BiotechnologiesBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$128.34M$2.93B$5.01B$8.81BDividend YieldN/A1.89%5.16%4.06%P/E Ratio-1.0345.25134.3717.77Price / Sales35.65360.241,158.6875.18Price / CashN/A160.0933.5332.53Price / Book0.753.734.674.68Net Income-$117.17M-$41.63M$119.07M$226.08M7 Day Performance-14.90%-4.73%-1.83%-1.04%1 Month Performance-25.30%-6.53%-3.62%1.04%1 Year Performance-28.26%25.63%31.63%26.28% Adverum Biotechnologies Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ADVMAdverum Biotechnologies4.1701 of 5 stars$6.17-1.3%$27.83+351.1%-32.5%$128.34M$3.60M-1.03190Analyst ForecastShort Interest ↓BDTXBlack Diamond Therapeutics2.8365 of 5 stars$2.43-4.7%$15.50+537.9%+8.0%$137.49MN/A-1.8390Positive NewsCHRSCoherus BioSciences3.8225 of 5 stars$1.10+34.1%$6.13+456.8%-46.9%$94.65M$304.34M-13.75246High Trading VolumeCRTXCortexymeN/A$1.84+4.0%N/A+101.1%$55.48MN/A-0.6255CCCCC4 Therapeutics2.6434 of 5 stars$4.05-2.4%$10.00+146.9%+139.6%$285.89M$33.67M-2.38150Analyst ForecastSGMOSangamo Therapeutics2.183 of 5 stars$1.95-0.5%$7.00+259.0%+369.9%$408.95M$176.23M0.00480Analyst RevisionGap UpPRTCPureTech Health2.2347 of 5 stars$21.70+2.1%$45.00+107.4%+0.9%$508.96M$3.33M0.00100News CoveragePositive NewsTERNTerns Pharmaceuticals4.3236 of 5 stars$5.60-5.2%$27.25+386.6%+49.3%$501.99M$1M0.0040MREOMereo BioPharma Group2.9648 of 5 stars$3.58+2.6%$7.50+109.5%+63.5%$489.50M$10M0.0040Analyst RevisionARCTArcturus Therapeutics2.0511 of 5 stars$16.17-10.5%$71.40+341.6%-33.7%$489.19M$142.47M-7.28180YMABY-mAbs Therapeutics3.3302 of 5 stars$10.54-2.9%$21.38+102.8%+100.8%$486.41M$84.82M0.00150Analyst Forecast Related Companies and Tools Related Companies BDTX Alternatives CHRS Alternatives CRTX Alternatives CCCC Alternatives SGMO Alternatives PRTC Alternatives TERN Alternatives MREO Alternatives ARCT Alternatives YMAB Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:ADVM) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adverum Biotechnologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Adverum Biotechnologies With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ADVM Stock Alerts